Manufacturer
Gland Pharma Limited
Contents
Zoledronic acid anhydrous 4mg.
Indication
Bone metastases associated with solid tumours, Osteolytic lesions associated with multiple myeloma, Hypercalcaemia of malignancy.
Instruction
Administer via IV Infusion
Drug interaction
Increased exposure of concomitant drugs eliminated by renal excretion (e.g. digoxin). Increased risk of hypocalcaemia w/ loop diuretics. Lowered serum Ca concentrations for prolonged periods w/ aminoglycosides. Increased risk of renal dysfunction w/ nephrotoxic agents.
Malaysia
